PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug ...
After the U.S. Food and Drug Administration announced an investigation into reports of leaks, breakages and other quality issues with China-made plastic syringes, New Jersey-based medical technology ...
PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of insulin injection devices in the world, today announced ...
The MarketWatch News Department was not involved in the creation of this content. Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and Globally SANTA BARBARA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback